Table 1.

First market approvals and current indications of ivermectin by country

Region	First Approval Date	Current Indications
Francea	October 1987	Onchocerciasis, strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
United Statesb	November 1996	Onchocerciasis, strongyloidiasis
Australiac	June 1997	Onchocerciasis, strongyloidiasis, human sarcoptic scabies, crusted scabies
Japand	October 2002	Strongyloidiasis, human sarcoptic scabies, crusted scabies
Netherlandse	March 2003	Strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
New Zealandf	August 2005	Strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
Germanya	February 2016	Strongyloidiasis, lymphatic filariasis, human sarcoptic scabies
Canadag	September 2018	Onchocerciasis, strongyloidiasis

^aEuropean Medicines Agency. Ivermectin (systemic use): List of nationally authorized medicinal products. Human Medicines Evaluation Division. Available at (accessed February 3, 2019): [https://www.ema.europa.eu/documents/psusa/ivermectin-systemic-use-list-nationally-authorised-medicinal-products-psusa/00002959/201502_en.pdf]

^bFood and Drug Administration. Labelling and Clinical Review of Final Printed Labelling: Stromectol (Ivermectin) 3 mg tablets (New Formulation). Center for Drug Evaluation and Research. 2000. Available at (accessed February 3, 2019): [https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/50-742s001_Stromectol_AdminCorres.PDF]

^cTherapeutic Goods Administration. AusPAR Product Information: Stromectol Tablets. 2013 Jul; Accessible at (accessed February 3, 2019): [https://www.tga.gov.au/sites/default/files/auspar-ivermectin-131030-pi.pdf]

^dPharmaceuticals and Medical Devices Agency. FY2006 List of Approved Products: New Drugs. 2006; Available at (accessed February 3, 2019): [https://www.pmda.go.jp/files/000153730.pdf]

^eMedicines Evaluation Board. Public Assessment Report – Scientific Discussion: Ivermectin Substipharm 3 mg tablets. 2018 Jul; Accessible at (accessed February 3, 2019): [https://db.cbg-meb.nl/Pars/h120488.pdf]

^fMedsafe. Medsafe Product Detail: Stromectol tablet 3 mg. 2018 Feb; Accessible at (accessed February 3, 2019): [https://www.medsafe.govt.nz/regulatory/ProductDetail.asp?ID=11299]

^gHealth Canada. Drug and health product submissions under review (SUR). Government of Canada. 2018. Available at (accessed February 3, 2019): [https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/submissions-under-review.html]